Which of the following is a positive acute-phase reactant?

Prepare for the Clinical Chemistry II Test. Utilize flashcards and multiple-choice questions with hints and detailed explanations to enhance your knowledge. Gain confidence for your exam success!

Multiple Choice

Which of the following is a positive acute-phase reactant?

Explanation:
Positive acute-phase reactants are proteins produced by the liver whose levels rise during inflammation. C-reactive protein is a classic example: its production is upregulated by inflammatory cytokines (like IL-6), causing rapid increases in the blood within hours and peaking within a day or two, then falling as the inflammation resolves. This makes CRP a sensitive marker for inflammation and infection. Albumin and transferrin behave oppositely—they decrease during the acute-phase response, so they are negative acute-phase reactants. Antithrombin isn’t considered a classic acute-phase reactant; its levels can change in illness due to factors like consumption or loss, but it’s primarily a coagulation inhibitor rather than a marker of the acute-phase response. Hence, CRP is the positive acute-phase reactant.

Positive acute-phase reactants are proteins produced by the liver whose levels rise during inflammation. C-reactive protein is a classic example: its production is upregulated by inflammatory cytokines (like IL-6), causing rapid increases in the blood within hours and peaking within a day or two, then falling as the inflammation resolves. This makes CRP a sensitive marker for inflammation and infection. Albumin and transferrin behave oppositely—they decrease during the acute-phase response, so they are negative acute-phase reactants. Antithrombin isn’t considered a classic acute-phase reactant; its levels can change in illness due to factors like consumption or loss, but it’s primarily a coagulation inhibitor rather than a marker of the acute-phase response. Hence, CRP is the positive acute-phase reactant.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy